Tens of millions of baby boomers are expected to live long enough to develop Alzheimer’s, and just about as many are worried about those prospects. One of them is a writer on Cape Cod named Susan Moeller. A recent memory lapse prompted her to publish her hopes, fears and observations.

Going by structural MRI of the brain, older people under 80 who have normal cognitive function but poor sleep quality are at heightened risk of developing Alzheimer’s disease or amnestic mild cognitive impairment (aMCI).

Brain imaging, using MRI, CT and ultrasound, may predict neurodevelopmental health in infants who have been exposed to the virus in utero, according to research published Dec. 12 in the New England Journal of Medicine.

AMRA, a medical technology company based out of Linköping, Sweden, has received FDA clearance for AMRA Profiler, an MR solution that measures a patient’s fat volumes, fat fractions and lean tissue volumes.

Compared to screen film mammography, researchers found digital mammography could more clearly depict calcifications, see through denser breast tissue and allowed the reader to adjust the actual image, according to a new study published Dec. 11 in Radiology.

In patients with prostate cancer, accurate primary staging is important for developing a treatment strategy. A study published in the December issue of the Journal of Nuclear Medicine found whole-body PET/MRI may offer a “one-stop-shop” to do so.

Free non-invasive prostate cancer screenings using multi-parametric MRI—which combines up to three different types of scans for a clearer image of the prostate—may soon be introduced in the U.K., according to a recent report by BBC News.

The Washington University School of Medicine in St. Louis (WUSTL) was awarded a five-year, $6.3 million grant to establish a new research center to develop and test novel PET tracers.